Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Fosaprepitant dimeglumine；MK-0517;Fosaprepitant dimeglumine salt;L785298 | C30H39F7N5O11P | 265121-04-8 | Details |
| Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH；E3 ligase Ligand-Linker Conjugates 49;Cereblon Ligand-Linker Conjugates 14 | C31H44N4O11 | 2351103-63-2 | Details |
| Pomalidomide-PEG1-C2-N3；Cereblon Ligand-Linker Conjugates 13;E3 ligase Ligand-Linker Conjugates 50 | C17H18N6O5 | 2271036-44-1 | Details |
| VHL Ligand-Linker Conjugates 15；E3 Ligase Ligand-Linker Conjugates 56 | C37H45FN4O8S | 2375564-62-6 | Details |
| (S,R,S)-AHPC-PEG3-N3；E3 ligase Ligand-Linker Conjugates 12;VHL Ligand-Linker Conjugates 8;VH032-PEG3-N3 | C30H43N7O7S | 1797406-80-4 | Details |
| Ceritinib；LDK378 | C28H36ClN5O3S | 1032900-25-6 | Details |
| (S,R,S)-AHPC-PEG2-C4-Cl；VH032-PEG2-C4-Cl;VHL Ligand-Linker Conjugates 7;E3 ligase Ligand-Linker Conjugates 10 | C32H47ClN4O6S | 1835705-57-1 | Details |
| (S,R,S)-AHPC-C6-PEG3-C4-Cl；VH032-C6-PEG3-C4-Cl;E3 ligase Ligand-Linker Conjugates 8;VHL Ligand-Linker Conjugates 12 | C38H59ClN4O7S | 1835705-55-9 | Details |
| (S,R,S)-AHPC-(C3-?PEG)?2-?C6-?Cl；VHL Ligand-Linker Conjugates 11;E3 ligase Ligand-Linker Conjugates 11 | C39H61ClN4O6S | 1835705-61-7 | Details |
| (S,R,S)-AHPC-PEG2-N3；VH032-PEG2-N3;E3 ligase Ligand-Linker Conjugates 13;VHL Ligand-Linker Conjugates 6 | C28H39N7O6S | 2010159-45-0 | Details |
| Thalidomide-O-amido-C3-COOH；E3 ligase Ligand-Linker Conjugates 15;Cereblon Ligand-Linker Conjugates 7 | C19H19N3O8 | 2308035-51-8 | Details |
| Thalidomide-O-amido-PEG3-C2-NH2；E3 Ligase Ligand-Linker Conjugates 14;Cereblon Ligand-Linker Conjugates 3 | C23H30N4O9 | 1957236-20-2 | Details |
| Pomalidomide-PEG4-C2-NH2；Cereblon Ligand-Linker Conjugates 8;E3 Ligase Ligand-Linker Conjugates 22 | C23H32N4O8 | 2225940-52-1 | Details |
| Thalidomide-O-amido-PEG2-C2-NH2 TFA；Cereblon Ligand-Linker Conjugates 10 TFA;E3 Ligase Ligand-Linker Conjugates 24 TFA | C23H27F3N4O10 | 1957235-75-4 | Details |
| Ceritinib dihydrochloride；LDK378 dihydrochloride | C28H37Cl2N5O3S | 1380575-43-8 | Details |
| Regorafenib；Fluoro-Sorafenib;BAY 73-4506 | C21H15ClF4N4O3 | 755037-03-7 | Details |
| (S,R,S)-AHPC-PEG1-N3；E3 ligase Ligand-Linker Conjugates 3;VHL Ligand-Linker Conjugates 9;VH032-PEG1-N3 | C26H35N7O5S | 2101200-09-1 | Details |
| (S,R,S)-AHPC-PEG4-N3；VH032-PEG4-N3;E3 ligase Ligand-Linker Conjugates 4;VHL Ligand-Linker Conjugates 5 | C32H47N7O8S | 1797406-81-5 | Details |
| (S,R,S)-AHPC-PEG3-NH2 hydrochloride；VH032-PEG3-NH2 hydrochloride;E3 ligase Ligand-Linker Conjugates 5;VHL Ligand-Linker Conjugates 1 hydrochloride | C30H46ClN5O7S | 2097971-11-2 | Details |
| (S,R,S)-AHPC-PEG3-NH2；E3 ligase Ligand-Linker Conjugates 5 Free Base;VH032-PEG3-NH2;VHL Ligand-Linker Conjugates 1 | C30H45N5O7S | 2010159-56-3 | Details |
| (S,R,S)-AHPC-PEG2-NH2 hydrochloride；E3 ligase Ligand-Linker Conjugates 6;VH032-PEG2-NH2 hydrochloride;VHL Ligand-Linker Conjugates 3 hydrochloride | C28H42ClN5O6S | 2097973-72-1 | Details |
| (S,R,S)-AHPC-PEG2-NH2；VH032-PEG2-NH2;VHL Ligand-Linker Conjugates 3;E3 ligase Ligand-Linker Conjugates 6 Free Base | C28H41N5O6S | 2010159-60-9 | Details |
| (S,R,S)-AHPC-PEG6-C4-Cl；VHL Ligand-Linker Conjugates 10;VH032-PEG6-C4-Cl;E3 ligase Ligand-Linker Conjugates 9 | C40H63ClN4O10S | 1835705-59-3 | Details |
| (S,R,S)-AHPC TFA；VH032-NH2 TFA;VHL ligand 1 TFA | C24H31F3N4O5S | 1631137-51-3 | Details |
| Lenalidomide-C5-NH2；E3 ligase Ligand-Linker Conjugates 31;Cereblon Ligand-Linker Conjugates 19 | C18H23N3O3 | 2093388-45-3 | Details |
| EC089 | C36H46N14O14S | 625827-91-0 | Details |
| MBX-2982；MBX2982 | C22H24N8OS | 1037792-44-1 | Details |
| EC1167 | C33H45N7O17S | 1610414-00-0 | Details |
| endo-BCN-PEG2-C2-NHS ester | C22H30N2O8 | 2243565-12-8 | Details |
| endo-BCN-PEG3-mal | C26H37N3O8 | 2141976-33-0 | Details |
| endo-BCN-PEG3-NH2 | C19H32N2O5 | 1883512-27-3 | Details |
| endo-BCN-PEG3-NHS ester | C24H34N2O9 | 2101206-94-2 | Details |
| Micafungin sodium；Mycamine Sodium;FK 463;FK463 Sodium | C56H72N9NaO23S | 208538-73-2 | Details |
| Estrone-N-O-C1-amido；ERα ligand 1 | C20H26N2O3 | 138219-84-8 | Details |
| exo BCN-O-PNB | C17H17NO5 | 1380006-72-3 | Details |
| FAK ligand-Linker Conjugate 1 | C25H28F3N5O6S | 2307461-45-4 | Details |
| Fluorescein-PEG5-NHS ester | C38H41N3O14S | 2353409-62-6 | Details |
| Fmoc-Ala-Ala-Asn-PABC-PNP | C39H38N6O11 | 1834516-06-1 | Details |
| Fmoc-Ala-Ala-Asn(Trt)-OH | C44H42N4O7 | 1951424-92-2 | Details |
| Carfilzomib；PR-171 | C40H57N5O7 | 868540-17-4 | Details |
| Fmoc-Asp-NH2 | C19H18N2O5 | 200335-40-6 | Details |
| Fmoc-Gly-Gly-OH | C19H18N2O5 | 35665-38-4 | Details |
| Fmoc-Gly-Gly-Phe-OtBu | C32H35N3O6 | 236426-37-2 | Details |
| Fmoc-NH-PEG12-CH2CH2COOH | C42H65NO16 | 1952360-91-6 | Details |
| Fmoc-N-PEG20-acid | C58H97NO24 | 1952360-93-8 | Details |
| Otenabant hydrochloride；Otenabant (CP-945598) HCl;Otenabant;CP 945598 Hydrochloride | C25H26Cl3N7O | 686347-12-6 | Details |
| Fmoc-N-PEG24-acid | C66H113NO28 | 2170484-59-8 | Details |
| Fmoc-N-PEG7-acid | C32H45NO11 | 1863885-74-8 | Details |
| Fmoc-NH-PEG10-acid | C38H57NO14 | 2101563-45-3 | Details |
| Fmoc-NH-PEG12-CH2COOH | C41H63NO16 | 2291257-76-4 | Details |
| Fmoc-NH-PEG15-CH2CH2COOH | C48H77NO19 | 2378590-46-4 | Details |
| Cabozantinib S-malate；Cabozantinib Malate;Cabozantinib;XL184 | C32H30FN3O10 | 1140909-48-3 | Details |
| Fmoc-NH-PEG3-C2-NH2 | C23H30N2O5 | 906126-25-8 | Details |
| Fmoc-NH-PEG4-alcohol | C23H29NO6 | 868594-41-6 | Details |
| Fmoc-NMe-PEG4-NHS ester | C31H38N2O10 | 2228857-30-3 | Details |
| Fmoc-PEA | C17H18NO6P | 329223-23-6 | Details |
| Fmoc-PEG12-NHS ester | C46H68N2O18 | 2227246-92-4 | Details |
| RITA；NSC 652287;RITA (NSC 652287) | C14H12O3S2 | 213261-59-7 | Details |
| Fmoc-Phe-Lys(Trt)-PAB-PNP | C63H57N5O9 | 1116086-09-9 | Details |
| Fmoc-Phe-Lys(Boc)-PAB-PNP | C49H51N5O11 | 1646299-50-4 | Details |
| Fmoc-Val-Cit-PAB-MMAE | C73H104N10O14 | 1350456-56-2 | Details |
| Folate-PEG3-azide | C27H35N11O8 | 1313026-32-2 | Details |
| Gly-Gly-Gly-PEG3-TCO | C23H41N5O8 | 2353409-81-9 | Details |
| Gly-Gly-Gly-PEG4-DBCO | C35H46N6O9 | 2353409-80-8 | Details |
| Gly-Gly-Gly-PEG4-methyltetrazine | C23H34N8O7 | 2353409-82-0 | Details |
| Gly-PEG3-endo-BCN | C23H39N3O6 | 2354291-37-3 | Details |
| Caspofungin Acetate；L 743873;L 743872;Cancidas;MK 0991 | C54H92N10O17 | 179463-17-3 | Details |
| H2N-PEG4-Hydrazide | C11H25N3O5 | 1425973-15-4 | Details |
| Halo PROTAC 1 | C33H49Cl2N7O8S | 2241668-45-9 | Details |
| VH032-PEG5-C6-Cl；HaloPROTAC 2 | C38H59ClN4O9S | 1799506-06-1 | Details |
| GW788388；GW 788388 | C25H23N5O2 | 452342-67-5 | Details |
| HO-PEG10-CH2COOH | C22H44O13 | 2250056-53-0 | Details |
| HO-PEG13-OH | C26H54O14 | 17598-96-8 | Details |
| SR9243 | C31H32BrNO4S2 | 1613028-81-1 | Details |
| HO-PEG16-OH | C32H66O17 | 6812-36-8 | Details |
| HO-PEG24-OH | C48H98O25 | 2243942-52-9 | Details |
| HO-PEG6-CH2COOH | C14H28O9 | 120394-66-3 | Details |
| HO-PEG8-CH2COOH | C18H36O11 | 780006-30-6 | Details |
| HS-27 | C52H60N6O12S | 1562024-11-6 | Details |
| ZLN005 | C17H18N2 | 49671-76-3 | Details |
| HS-PEG11-CH2CH2N3 | C24H49N3O11S | 2148986-08-5 | Details |
| HS-PEG3-CH2CH2N3；Thiol-PEG3-C2-azide | C8H17N3O3S | 1347750-79-1 | Details |
| HS-PEG3-CH2CH2NH2；Thiol-PEG3-amine | C8H19NO3S | 1189760-69-7 | Details |
| HS-PEG5-CH2CH2N3 | C12H25N3O5S | 1449390-11-7 | Details |
| HS-PEG5-CH2CH2NH2；Thiol-PEG5-amine | C12H27NO5S | 1347750-20-2 | Details |
| HS-PEG7-CH2CH2N3 | C16H33N3O7S | 2148986-06-3 | Details |
| GNF-5；GNF 5;GNF5 | C20H17F3N4O3 | 778277-15-9 | Details |
| Hydroxy-PEG10-acid；HO-PEG10-CH2CH2COOH | C23H46O13 | 2375611-66-6 | Details |
| Hydroxy-PEG12-Boc；Hydroxy-PEG12-T-Butyl Ester | C31H62O15 | 2388521-20-6 | Details |
| HPGDS inhibitor 1；HPGDS-inhibitor-1 | C19H19F4N3O | 1033836-12-2 | Details |
| Hydroxy-PEG4-C2-methyl ester | C12H24O7 | 2228857-35-8 | Details |
| Hydroxy-PEG4-C2-nitrile | C11H21NO5 | 2194563-83-0 | Details |
| Hydroxy-PEG7-CH2-Boc；HO-PEG7-CH2COOtBu | C20H40O10 | 2378049-28-4 | Details |
| Ibrutinib-biotin | C56H80N12O9S | 1599432-18-4 | Details |
| Ataluren；PTC124 | C15H9FN2O3 | 775304-57-9 | Details |
| Iodoacetamide-PEG3-azide | C10H19IN4O4 | 1594986-04-5 | Details |
| Ipatasertib-NH2；RG7440-NH2;GDC-0068-NH2 | C21H26ClN5O2 | 1001382-14-4 | Details |
| K-Ras ligand-Linker Conjugate 3 | C49H65N7O10S | 2378261-87-9 | Details |
| K-Ras ligand-Linker Conjugate 4 | C35H51N7O8 | 2378261-83-5 | Details |
| Product Total： Product Page： | ||||
| 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 | ||||